Bulletin
Investor Alert

Intercept Pharmaceuticals Inc.

NAS: ICPT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202434567/composite

$

15.41

Change

-0.13 -0.84%

Volume

Volume 23,228

Jan 28, 2022, 7:57 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202434567/composite

Previous close

$ 14.44

$ 15.54

Change

+1.10 +7.62%

Day low

Day high

$13.89

$15.75

Open
Open: 14.58

52 week low

52 week high

$11.60

$38.20

Open

Market cap

$426.66M

Average volume

861,178

P/E ratio

N/A

Rev. per Employee

$711,510

EPS

-3.25

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/icpt

MarketWatch News on ICPT

  1. Intercept Pharmaceuticals stock price target cut to $31 from $43 at Canaccord Genuity

    8:22 a.m. Aug. 3, 2021

    - Tomi Kilgore

  2. The FDA's Biogen Decision Will Cause Waves Across Biotech

    8:20 p.m. June 1, 2021

    - Barron's Online

  3. Intercept Pharmaceuticals downgraded to neutral from buy at B. Riley

    6:23 a.m. May 26, 2021

    - Tomi Kilgore

  4. Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR

    7:28 a.m. Nov. 20, 2020

    - Tomi Kilgore

  5. Intercept Pharmaceuticals upgraded to outperform from market perform at Raymond James

    7:47 a.m. Nov. 10, 2020

    - Tomi Kilgore

  6. Intercept shares gain after it announces layoffs

    7:19 a.m. Sept. 2, 2020

    - Jaimy Lee

  7. A Top Contender Drops Out of Race for a NASH Drug

    10:15 a.m. July 23, 2020

    - Barron's Online

  8. Biogen Submits Troubled Alzheimer’s Drug for FDA Approval

    11:07 a.m. July 8, 2020

    - Barron's Online

  9. Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.

    10:53 a.m. June 30, 2020

    - Barron's Online

  10. Intercept Pharmaceuticals downgraded to market perform at BMO Capital

    8:07 a.m. June 30, 2020

    - Tomi Kilgore

  11. Intercept Pharmaceuticals stock price target cut to $97 from $158 at B. Riley FBR

    6:53 a.m. June 30, 2020

    - Tomi Kilgore

  12. Intercept Pharmaceuticals stock price target cut to $50 from $89 at SVB Leerink

    5:11 a.m. June 30, 2020

    - Tomi Kilgore

  13. Intercept Shares Tumble on NASH Disappointment

    3:05 p.m. June 29, 2020

    - Barron's Online

  14. Intercept's stock plunges 35% premarket after receiving CRL from FDA for treatment of fibrosis due to NASH

    6:17 a.m. June 29, 2020

    - Tomi Kilgore

  15. Intercept Pharmaceuticals receives FDA letter for its treatment for fibrosis due to NASH

    6:15 a.m. June 29, 2020

    - Ciara Linnane

  16. Intercept Pharmaceuticals shares slide 35% premarket

    6:15 a.m. June 29, 2020

    - Ciara Linnane

  17. Intercept Pharmaceuticals started at outperform with $107 stock price target at BMO Capital

    7:35 a.m. June 5, 2020

    - Tomi Kilgore

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/icpt

Other News on ICPT

  1. Tech Selloff Pushes Ex-Unicorn Bonds Into Distressed Hands

    7:00 a.m. Jan. 14, 2022

    - Alexander Saeedy

  2. 3 Can't-Miss Biotech Events Coming Up in 2022

    5:41 a.m. Jan. 7, 2022

    - Motley Fool

  3. 3 Biotech Stocks With Major Catalysts in January

    6:26 a.m. Jan. 4, 2022

    - Motley Fool

  4. 10-Q: INTERCEPT PHARMACEUTICALS, INC.

    4:04 p.m. Nov. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. Loading more headlines...
/news/pressrelease/company/us/icpt

Press Releases on ICPT

  1. Intercept to Present at Upcoming Investor Conferences

    8:00 a.m. Nov. 11, 2021

    - GlobeNewswire

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.